可必勝凝膠(CARBOSAN GEL) |
衛署藥輸字第020059號 |
CARBENOXOLONE SODIUM |
2009-12-23 |
喉立順噴液劑0.2毫克/毫升(Holisoon Spray Solution 0.2mg/mL) |
衛部藥製字第058347號 |
AZULENE SODIUM SULFONATE |
2014-08-27 |
喉立順噴液劑0.2毫克/毫升(Holisoon Spray Solution 0.2mg/mL) |
衛部藥製字第058347號 |
AZULENE SODIUM SULFONATE |
2014-08-27 |
葉綠素錠(CHLOROPHYLL TABLETS) |
內衛藥製字第006438號 |
CHLOROPHYLLIN |
2015-12-21 |
"派頓"綠爽錠(GREENSOON TABLETS "PATRON") |
衛署藥製字第020733號 |
SODIUM COPPER CHLOROPHYLLIN |
2016-03-29 |
舒爽錠30公絲(葉綠素銅鈉)(SUSAN TABLETS 30MG (SODIUM COPPER CHLOROPHYLL." CM") |
衛署藥製字第025558號 |
SODIUM COPPER CHLOROPHYLLIN |
2015-11-18 |
利咳芬含錠(DECOUPHAN LOZENGES) |
衛署藥製字第020227號 |
PHENYLEPHRINE HCL, DEXTROMETHORPHAN HBR |
2015-05-12 |
〝長安〞夜半瞑口含錠(YEHPANMING TABLETS "C.E.") |
衛署藥製字第043256號 |
CAFFEINE ANHYDROUS, NICOTINAMIDE, THIAMINE MONONITRATE |
2015-12-29 |
感克嗽 口含錠(ANTI-COUGH TABLETS) |
衛署藥製字第043393號 |
DL-CHLORPHENIRAMINE MALEATE, GUAIACOL GLYCERYL ETHER (EQ TO GUAIFENESIN), NOSCAPINE |
2015-05-06 |
舒舒口含錠(S.S TABLETS) |
衛署藥製字第043333號 |
DL-CHLORPHENIRAMINE MALEATE, PSEUDOEPHEDRINE HCL, CARBETAPENTANE CITRATE (eq to Pentoxyverine Citrate), GUAIACOL GLYCOLATE (EQ TO GLYCERYL GUAIACOLATE) |
2015-11-04 |
利多斯本牙科局部麻醉注射劑(Lignospan Special) |
衛署藥輸字第025568號 |
ADRENALINE TARTRATE, LIDOCAINE HCL MONOHYDRATE |
2017-01-13 |
阿斯匹林(ASPIRIN) |
衛署藥陸輸字第000066號 |
ASPIRIN |
2016-05-31 |
乙醯水楊酸鋁(ALUMINUM ASPIRIN "P.L.") |
衛署藥製字第015683號 |
ALUMINUM BIS(ACETYLSALICYLATE)(ALUMINUM ACETYLSALICYLA |
2016-06-02 |
醋柳酸(ACETYLSALICYLIC ACID) |
衛署藥輸字第000241號 |
ASPIRIN |
2016-01-25 |
"波利" 離胺酸阿斯匹林粉劑(LYSINE ACETYLSALICYLATE) |
衛署藥輸字第013605號 |
LYSINE ACETYLSALICYLATE |
2014-06-13 |
乙醯水楊酸(ACETYLSALICYLIC ACID) |
衛署藥輸字第020116號 |
ASPIRIN |
2016-03-18 |
乙醯水楊酸(ACETYLSALICYLIC ACID) |
衛署藥輸字第022353號 |
ACETYLSALICYLIC ACID |
2013-08-23 |
"依默克"乙醯水揚酸(ACETYLSALICYLIC ACID SUITABLE FOR USE AS AN ACTIVE PHARMACEUTICAL INGREDIENT) |
衛署藥輸字第017912號 |
ASPIRIN |
2016-05-31 |
拜樂藥水(BYLUX EXTERNAL SOLUTION) |
衛署藥製字第032183號 |
ANTHRAQUINONE GLYCOSIDES, SALICYLIC ACID |
2016-06-23 |
乙醯水楊酸(ACETYLSALICYLIC ACID) |
衛署藥輸字第011045號 |
ASPIRIN |
2013-12-31 |